HealthMap

N-Acetylcysteine (NAC) and Influenza in the Elderly

Overview

• Clinical observation indicates that oral N-Acetylcysteine (NAC) supplementation can significantly attenuate influenza-like episodes in elderly subjects.
• Double-blind trials have demonstrated a major reduction in symptomatic illness duration and severity among older individuals receiving daily oral doses of NAC.

Key Physiological Effects

• Mucolytic action: Helps clear respiratory secretions, reducing airway congestion typical of viral infections.
• Glutathione precursor: Replenishes intracellular glutathione, enhancing overall immune system resilience and reducing oxidative stress.
• Symptom mitigation: While viral infection rates may remain comparable between groups, those receiving NAC experience a dramatic decrease in symptomatic severity and bedridden days.

Nutritional and Dosage Considerations

• Typical oral regimens used in clinical studies for elderly protection involve 600 mg taken twice daily.
• Bioavailability and individual response can vary, requiring careful assessment of overall antioxidant status and trace mineral balances.
• Always consult with a qualified health professional before initiating high-dose supplementation, particularly in the presence of gastrointestinal sensitivities or concurrent medications.